Saito Satoshi, Zempo Nobuya, Yamashita Akimasa, Takenaka Hiroaki, Fujioka Kentaro, Esato Kensuke
First Department of Surgery, Yamaguchi University School of Medicine, Yamaguchi, Japan.
Vasc Endovascular Surg. 2002 Jan-Feb;36(1):1-7. doi: 10.1177/153857440203600102.
Medial degeneration of extracellular matrix (ECM) proteins in the wall of abdominal aortas results in smooth muscle cell destruction, a loss of architectural integrity, and abdominal aortic aneurysm (AAA) formation. It has been theorized that an imbalance between proteinases and their naturally occurring inhibitors is the cause of these observed histologic abnormalities. Therefore, the purpose of this investigation was to determine if differences in the matrix metalloproteinase (MMP) -2 and -9, tissue inhibitor of metalloproteinase-1 (TIMP-1), tissue-type plasminogen activator (tPA), and urokinase-type plasminogen activator (uPA) protein and activity levels existed between infrarenal AAA and normal abdominal aortic tissue specimens. Between November 1995 and January 1997, 10 patients undergoing elective infrarenal AAA repair had a portion of their aneurysm walls snap frozen in liquid nitrogen and processed for subsequent western blot or zymographic analysis. Tissue specimens from 6 normal abdominal aortas obtained from fresh cadaver specimens were similarly processed and served as controls. Protein levels for MMP-2, MMP-9, TIMP-1, uPA, and tPA were analyzed by western blotting. The degree of MMP-2 and MMP-9 gelatinolytic activity was analyzed by zymography. Detection and immunolocalization for MMP-2, MMP-9 and CD68 was performed on tissue sections of AAA and normal infrarenal abdominal aortas fixed in 10% formalin. MMP-9 and tPA protein levels were increased in AAAs compared to controls by western blotting. However, uPA levels were slightly increased in controls. No differences in TIMP-1 protein levels were identified. Similarly, zymography demonstrated increased MMP-2 and MMP-9 gelatinolytic activity in AAAs compared to controls (p < or = 0.05). CD68-positive cells (macrophages) in the adventitia and media demonstrated immunoreactivity to MMP-9. This investigation demonstrated increased MMP-9 proteinase activity and tPA protein levels in the walls of AAAs, as well as inflammatory leukocyte invasion of the adventitia and media compared to controls. These data suggest that leukocyte-derived MMP-9 is associated with aortic wall degeneration and aneurysm formation. Furthermore, activation of MMP-9 may be caused by increased tPA levels in the walls of AAAs.
腹主动脉壁细胞外基质(ECM)蛋白的中层变性会导致平滑肌细胞破坏、结构完整性丧失以及腹主动脉瘤(AAA)形成。理论上认为,蛋白酶与其天然存在的抑制剂之间的失衡是这些观察到的组织学异常的原因。因此,本研究的目的是确定肾下腹主动脉瘤与正常腹主动脉组织标本之间基质金属蛋白酶(MMP)-2和-9、金属蛋白酶组织抑制剂-1(TIMP-1)、组织型纤溶酶原激活剂(tPA)和尿激酶型纤溶酶原激活剂(uPA)的蛋白及活性水平是否存在差异。1995年11月至1997年1月期间,10例行择期肾下腹主动脉瘤修复术的患者,其部分动脉瘤壁在液氮中速冻,并进行后续的蛋白质印迹或酶谱分析。从新鲜尸体标本获取的6个正常腹主动脉的组织标本也进行类似处理并作为对照。通过蛋白质印迹分析MMP-2、MMP-9、TIMP-1、uPA和tPA的蛋白水平。通过酶谱分析MMP-2和MMP-9的明胶酶解活性程度。对固定于10%福尔马林中的腹主动脉瘤和正常肾下腹主动脉组织切片进行MMP-2、MMP-9和CD68的检测及免疫定位。通过蛋白质印迹分析,与对照组相比,腹主动脉瘤中MMP-9和tPA蛋白水平升高。然而,对照组中uPA水平略有升高。未发现TIMP-1蛋白水平存在差异。同样,酶谱分析表明,与对照组相比,腹主动脉瘤中MMP-2和MMP-9的明胶酶解活性增加(p≤0.05)。外膜和中膜中的CD68阳性细胞(巨噬细胞)对MMP-9呈免疫反应性。本研究表明,与对照组相比,腹主动脉瘤壁中MMP-9蛋白酶活性和tPA蛋白水平升高,外膜和中膜存在炎性白细胞浸润。这些数据表明,白细胞来源的MMP-9与主动脉壁变性和动脉瘤形成有关。此外,腹主动脉瘤壁中tPA水平升高可能导致MMP-9激活。